Kaiwu Xu

536 total citations
18 papers, 428 citations indexed

About

Kaiwu Xu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kaiwu Xu has authored 18 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Kaiwu Xu's work include DNA Repair Mechanisms (6 papers), PARP inhibition in cancer therapy (5 papers) and Cell death mechanisms and regulation (4 papers). Kaiwu Xu is often cited by papers focused on DNA Repair Mechanisms (6 papers), PARP inhibition in cancer therapy (5 papers) and Cell death mechanisms and regulation (4 papers). Kaiwu Xu collaborates with scholars based in China and Israel. Kaiwu Xu's co-authors include Xinming Song, Zhihui Chen, Yulong He, Changjiang Qin, Ertao Zhai, Kaiming Wu, Jianhui Chen, Kuanzhi Liu, Xuequn Ren and Jiehong Huang and has published in prestigious journals such as Medicine, The International Journal of Biochemistry & Cell Biology and Cell Death and Disease.

In The Last Decade

Kaiwu Xu

18 papers receiving 422 citations

Peers

Kaiwu Xu

ONCOL

PRM

SURGE

Xi-Zhao Li China

Kwan Chee Allen Chan Hong Kong

Burcu Çakar Türkiye

Chieh-Lun Hsiao Taiwan

Nur Rahadiani Indonesia

Fabrizio Citarella Italy

Christine Burns United States

Sidrah Shah United Kingdom

Guo-Ping Shen China

Oliver Stötzer Germany

Xi-Zhao Li China

Kaiwu Xu

210 ×0.8

118 ×0.7

ONCOL

42 ×0.6

PRM

60 ×1.1

SURGE

Citations per year, relative to Kaiwu Xu Kaiwu Xu (= 1×) peers Xi-Zhao Li

Countries citing papers authored by Kaiwu Xu

Since Specialization

Citations

This map shows the geographic impact of Kaiwu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiwu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiwu Xu more than expected).

Fields of papers citing papers by Kaiwu Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaiwu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiwu Xu. The network helps show where Kaiwu Xu may publish in the future.

Co-authorship network of co-authors of Kaiwu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kaiwu Xu. A scholar is included among the top collaborators of Kaiwu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiwu Xu. Kaiwu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Xu, Kaiwu, et al.. (2024). PARP1 bound to XRCC2 promotes tumor progression in colorectal cancer. Discover Oncology. 15(1). 238–238. 1 indexed citations

Zhai, Ertao, Kaiwu Xu, Yijie Zhang, et al.. (2022). PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells. Cell Death and Disease. 13(5). 505–505. 25 indexed citations

Liu, Qi, et al.. (2022). LncRNA OGFRP1 promotes angiogenesis and epithelial-mesenchymal transition in colorectal cancer cells through miR-423-5p/CTCF axis. Immunobiology. 227(2). 152176–152176. 9 indexed citations

Ren, Hui, Zhihui Chen, Liang Yang, et al.. (2019). <p>Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer</p>. Cancer Management and Research. Volume 11. 4917–4930. 59 indexed citations

Wu, Kaiming, Jun Ma, Kuanzhi Liu, et al.. (2018). Down-Regulation of MicroRNA-214 Contributed to the Enhanced Mitochondrial Transcription Factor A and Inhibited Proliferation of Colorectal Cancer Cells. Cellular Physiology and Biochemistry. 49(2). 545–554. 23 indexed citations

Wu, Kaiming, Kaiwu Xu, Kuanzhi Liu, et al.. (2018). Long noncoding RNA BC200 regulates cell growth and invasion in colon cancer. The International Journal of Biochemistry & Cell Biology. 99. 219–225. 52 indexed citations

Yang, Liang, Zhihui Chen, Hui Ren, et al.. (2018). High expression of SLC17A9 correlates with poor prognosis in colorectal cancer. Human Pathology. 84. 62–70. 19 indexed citations

Liu, Jia, et al.. (2017). Pulmonary Rehabilitation after Stroke. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin. 27(6). 329–334. 3 indexed citations

Xu, Kaiwu, Zhihui Chen, Yi Cui, et al.. (2015). Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer. OncoTargets and Therapy. 8. 3047–3047. 30 indexed citations

10.

Yu, Yi, Hui Li, Kaiwu Xu, et al.. (2015). Dairy consumption and lung cancer risk: a meta-analysis of prospective cohort studies. OncoTargets and Therapy. 9. 111–111. 8 indexed citations

11.

Qin, Changjiang, Kaiwu Xu, Zhihui Chen, et al.. (2015). XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis. Tumor Biology. 36(2). 461–466. 11 indexed citations

12.

Qin, Changjiang, Xinming Song, Zhihui Chen, et al.. (2015). XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy. Oncotarget. 6(31). 32193–32204. 33 indexed citations

13.

Xu, Kaiwu, et al.. (2014). miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2. OncoTargets and Therapy. 7. 325–325. 69 indexed citations

14.

Xu, Kaiwu, et al.. (2014). XRCC2 Promotes Colorectal Cancer Cell Growth, Regulates Cell Cycle Progression, and Apoptosis. Medicine. 93(28). e294–e294. 27 indexed citations

15.

Xu, Kaiwu, Xinming Song, Zhihui Chen, Changjiang Qin, & Yulong He. (2014). XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor. Oncology Letters. 8(3). 1222–1228. 11 indexed citations

16.

Song, Xinming, Zhihui Chen, Mingzhe Li, et al.. (2014). Quality of life in rectal cancer patients after radical surgery: a survey of Chinese patients. World Journal of Surgical Oncology. 12(1). 161–161. 18 indexed citations

17.

Qin, Changjiang, et al.. (2014). Does Preoperative Radio(chemo)therapy Increase Anastomotic Leakage in Rectal Cancer Surgery? A Meta-Analysis of Randomized Controlled Trials. Gastroenterology Research and Practice. 2014. 1–7. 19 indexed citations

18.

Peng, Weidong, Xianmin Zhou, Xiaomin Cui, et al.. (1998). Transmission and Natural Regulation of Infection with Ascaris lumbricoides in a Rural Community in China. Journal of Parasitology. 84(2). 252–252. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact